Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney

• SHIMIZU Kazuaki

  Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University

• FURUICHI Kengo

  Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University

• SAKAI Norihiko

  Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University

• KITAGAWA Kiyoki

  Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University

• MATSUSHIMA Kouji

  Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo

• MUKAIDA Naofumi

  Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University

• KANEKO Shuichi

  Department of Disease Control and Homeostasis, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University

• WADA Takashi

  Department of Laboratory Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University

収録刊行物

• Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension

  Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension 34 (6), 747-752, 2011-06-01

キーワード

• CX3CR1
• fibrosis
• fractalkine
• kidney

詳細情報

• CRID: 1572824501016707200
• NII論文ID: 10031163247
• NII書誌ID: AA10847079
• ISSN: 09169636
• Web Site: https://search.jamas.or.jp/link/ui/2013012046
• 本文言語コード: en
• データソース種別:
  • CiNii Articles